Charite University, Berlin, Germany

This early-stage study is testing whether a personalized cell therapy called CAR-T (KYV-101) can work better than the standard drug rituximab for people with severe, treatment-resistant rheumatoid arthritis. It will enroll 13 patients to compare the safety of both treatments and …

This study is testing whether a drug called vericiguat, already approved for heart failure, can help people with Long COVID. It aims to see if the drug can improve their ability to do daily activities and reduce severe fatigue. About 104 adults aged 18-50 with Long COVID symptoms…

This study is testing if adding a special group therapy program to standard one-on-one therapy helps people with depression or anxiety. The group therapy focuses on improving how people interact with others. Researchers are comparing standard therapy alone to standard therapy plu…

This study aims to better predict how deep brain stimulation (DBS) surgery for Parkinson's disease might affect a patient's thinking and memory. Researchers will follow 30 Parkinson's patients before and for five years after their DBS surgery, collecting various health data to id…

This study analyzes existing hospital records from over 900,000 patients to identify which medications increase the risk of falls in older adults. Researchers are checking a German expert list of potentially risky medications and looking for additional drugs that should be includ…

This study is testing a special full-body suit that uses mild electrical stimulation on astronauts living on the International Space Station. The goal is to see if adding this stimulation to their regular exercise routine helps keep their muscles healthier and stronger during lon…